High-Grade Early-Onset Prostate Cancer: Assessment of TMPRSS2::ERG-Negative Tumors Suggests Low Frequency of Germline Alterations and a Pathogenic Role for HOXB13.

IF 4.2 1区 医学 Q1 PATHOLOGY
Daisy Maharjan, Stephanie Siegmund, Květoslava Michalova, Igor Odintsov, Jason L Hornick, Varsha Nair, Muhammad T Idrees, Katrina Collins, Jennifer B Gordetsky, Adeboye O Osunkoya, Liang Cheng, Hiroshi Miyamoto, Ankur R Sangoi, Douglas J Wu, Costantino Ricci, Veronica Mollica, Maria R Raspollini, Felix Contreras, Mariela P P Bernal, Isabel M Fernandez, Adriana Rodriguez, Anandi Lobo, Sambit K Mohanty, Shivani Sharma, Mustafa Goksel, Andres M Acosta
{"title":"High-Grade Early-Onset Prostate Cancer: Assessment of TMPRSS2::ERG-Negative Tumors Suggests Low Frequency of Germline Alterations and a Pathogenic Role for HOXB13.","authors":"Daisy Maharjan, Stephanie Siegmund, Květoslava Michalova, Igor Odintsov, Jason L Hornick, Varsha Nair, Muhammad T Idrees, Katrina Collins, Jennifer B Gordetsky, Adeboye O Osunkoya, Liang Cheng, Hiroshi Miyamoto, Ankur R Sangoi, Douglas J Wu, Costantino Ricci, Veronica Mollica, Maria R Raspollini, Felix Contreras, Mariela P P Bernal, Isabel M Fernandez, Adriana Rodriguez, Anandi Lobo, Sambit K Mohanty, Shivani Sharma, Mustafa Goksel, Andres M Acosta","doi":"10.1097/PAS.0000000000002459","DOIUrl":null,"url":null,"abstract":"<p><p>Early onset prostate cancer (EOPC; defined herein as prostate cancer [PCa] affecting men ≤ 55 years-old) tends to show low histologic grade, likely representing early detection of indolent tumors that would otherwise be diagnosed later in life. A small subset of EOPC exhibits Gleason scores consistent with high-risk disease (Grade Groups 4 to 5; high-grade EOPC [HG-EOPC] hereafter). In this study, we assess the clinicopathologic features of HG-EOPC, with genomic analysis of ERG-negative cases. We assessed HG-EOPC using immunohistochemistry for ERG (as a surrogate marker of TMPRSS2::ERG), PMS2 (as a surrogate marker of MLH1/PMS2 inactivation), and MSH6 (as a surrogate marker of MSH2/MSH6 inactivation). Selected ERG negative cases were assessed using Oncopanel, which interrogates 447 genes, including PCa-relevant genes. Ninety-six samples from 96 individual patients (median age: 52 y; range: 40 to 55 y) were included in the study. Immunohistochemical staining with ERG was performed in 95 cases, 52 (54%) of which showed negative staining. PMS2 was performed in 93 cases, being retained in 92 (98.9%) and lost in 1 (1.1%). MSH6 was performed in 96 cases, being retained in 92 (95.8%), lost in 2 (2.1%), and equivocal in 2 (2.1%). Sequencing of 23 ERG-negative primary tumors showed enrichment for alterations that are typically associated with castration resistance, including loss of 8p (>50%), gains of 8q (>50%), and inactivation of CDK12 (n=4). The cohort also showed a relatively high frequency of pathogenic TP53 (n=7) and SPOP (n=4) variants. Pathogenic BRCA2 variants and mismatch repair deficiency were identified in 1 case each. Interestingly, >50% of the tumors showed HOXB13 amplification. In conclusion, TMPRSS2::ERG fusion-negative HG-EOPC shows a high frequency of genomic alterations typically enriched in castration-resistant neoplasms but variants of potential germline origin (including those in mismatch repair genes) are rare. These results demonstrate that HG-EOPC is driven largely by somatic events.</p>","PeriodicalId":7772,"journal":{"name":"American Journal of Surgical Pathology","volume":" ","pages":""},"PeriodicalIF":4.2000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Surgical Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/PAS.0000000000002459","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Early onset prostate cancer (EOPC; defined herein as prostate cancer [PCa] affecting men ≤ 55 years-old) tends to show low histologic grade, likely representing early detection of indolent tumors that would otherwise be diagnosed later in life. A small subset of EOPC exhibits Gleason scores consistent with high-risk disease (Grade Groups 4 to 5; high-grade EOPC [HG-EOPC] hereafter). In this study, we assess the clinicopathologic features of HG-EOPC, with genomic analysis of ERG-negative cases. We assessed HG-EOPC using immunohistochemistry for ERG (as a surrogate marker of TMPRSS2::ERG), PMS2 (as a surrogate marker of MLH1/PMS2 inactivation), and MSH6 (as a surrogate marker of MSH2/MSH6 inactivation). Selected ERG negative cases were assessed using Oncopanel, which interrogates 447 genes, including PCa-relevant genes. Ninety-six samples from 96 individual patients (median age: 52 y; range: 40 to 55 y) were included in the study. Immunohistochemical staining with ERG was performed in 95 cases, 52 (54%) of which showed negative staining. PMS2 was performed in 93 cases, being retained in 92 (98.9%) and lost in 1 (1.1%). MSH6 was performed in 96 cases, being retained in 92 (95.8%), lost in 2 (2.1%), and equivocal in 2 (2.1%). Sequencing of 23 ERG-negative primary tumors showed enrichment for alterations that are typically associated with castration resistance, including loss of 8p (>50%), gains of 8q (>50%), and inactivation of CDK12 (n=4). The cohort also showed a relatively high frequency of pathogenic TP53 (n=7) and SPOP (n=4) variants. Pathogenic BRCA2 variants and mismatch repair deficiency were identified in 1 case each. Interestingly, >50% of the tumors showed HOXB13 amplification. In conclusion, TMPRSS2::ERG fusion-negative HG-EOPC shows a high frequency of genomic alterations typically enriched in castration-resistant neoplasms but variants of potential germline origin (including those in mismatch repair genes) are rare. These results demonstrate that HG-EOPC is driven largely by somatic events.

高级别早发性前列腺癌:TMPRSS2:: ergg阴性肿瘤的评估提示生殖系改变的低频率和HOXB13的致病作用。
早发性前列腺癌;此处定义为前列腺癌[PCa],影响≤55岁的男性),其组织学分级较低,可能代表了早期发现的惰性肿瘤,否则将在以后的生活中被诊断出来。一小部分EOPC的Gleason评分与高危疾病一致(4 - 5级组;高级EOPC [HG-EOPC]。在这项研究中,我们通过对ergg阴性病例的基因组分析来评估HG-EOPC的临床病理特征。我们使用免疫组织化学方法评估了HG-EOPC的ERG(作为TMPRSS2::ERG的替代标记)、PMS2(作为MLH1/PMS2失活的替代标记)和MSH6(作为MSH2/MSH6失活的替代标记)。选定的ERG阴性病例使用oncoppanel进行评估,该工具询问447个基因,包括pca相关基因。96例患者的96份样本(中位年龄:52岁;范围:40至55岁)被纳入研究。95例行ERG免疫组化染色,其中52例(54%)呈阴性。93例行PMS2,保留92例(98.9%),丢失1例(1.1%)。96例行MSH6,保留92例(95.8%),丢失2例(2.1%),模棱两可2例(2.1%)。对23例ergg阴性原发肿瘤的测序显示,与去势抗性相关的改变富集,包括8p缺失(>50%)、8q增加(>50%)和CDK12失活(n=4)。该队列还显示致病性TP53 (n=7)和SPOP (n=4)变异的频率相对较高。致病性BRCA2变异和错配修复缺陷各1例。有趣的是,50%的肿瘤显示HOXB13扩增。总之,TMPRSS2::ERG融合阴性的hc - eopc显示出高频率的基因组改变,通常在去势抵抗肿瘤中丰富,但潜在的种系起源变异(包括错配修复基因的变异)是罕见的。这些结果表明HG-EOPC主要由体细胞事件驱动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.30
自引率
5.40%
发文量
295
审稿时长
1 months
期刊介绍: The American Journal of Surgical Pathology has achieved worldwide recognition for its outstanding coverage of the state of the art in human surgical pathology. In each monthly issue, experts present original articles, review articles, detailed case reports, and special features, enhanced by superb illustrations. Coverage encompasses technical methods, diagnostic aids, and frozen-section diagnosis, in addition to detailed pathologic studies of a wide range of disease entities. Official Journal of The Arthur Purdy Stout Society of Surgical Pathologists and The Gastrointestinal Pathology Society.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信